Comité consultatif de pathologistes sur la mise en œuvre : Conseils relatifs aux rapports de classifications diagnostiques de cancer du sein
Wed, 18 Oct 2023 11:19:43 -0400
Wed, 18 Oct 2023 11:19:43 -0400
Hamilton recalls their HAMILTON-C1, T1, MR-1 ventilators for capacitators that may leak electrolyte onto the control board and cause short circuiting.
Mon, 16 Oct 2023 16:22:30 -0400
In adolescents and children aged 10 years and above with type 2 diabetes, Victoza is indicated as an adjunct to metformin with or without basal insulin, when diet and exercise plus maximal tolerated dose of metformin do not achieve adequate glycemic control.
Mon, 16 Oct 2023 16:19:17 -0400
In combination with bortezomib, thalidomide and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.
Mon, 16 Oct 2023 16:15:58 -0400
In combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation in pediatric patients older than 1 year old with AML or MDS.
Mon, 16 Oct 2023 16:11:17 -0400
For the treatment of pediatric patients 1 year of age and older with low-grade glioma with a BRAF V600E mutation who require systemic therapy.
For the treatment of pediatric patients 1 year of age and older with high-grade glioma with a BRAF V600E mutation who have received at least one prior radiation and/or chemotherapy treatment.
Mon, 16 Oct 2023 16:07:36 -0400
Adolescents and children (aged 6 years and older) who are inadequately controlled with medium-to-high-dose inhaled corticosteroids and an additional asthma controller (e.g., LABA); and who have a blood eosinophil count of ≥ 150 cells/mcL (0.15 GI/L) at initiation of treatment with Nucala OR ≥ 300 cells/mcL (0.3 GI/L) in the past 12 months.
Mon, 16 Oct 2023 15:52:19 -0400
As an add-on maintenance treatment with intranasal corticosteroids in adult patients with severe chronic rhinosinusitis with nasal polyps inadequately controlled by intranasal corticosteroids alone.
Mon, 16 Oct 2023 15:46:00 -0400
Long-term, once-daily, maintenance treatment of asthma in patients aged 18 years and older who are not adequately controlled with a maintenance combination of a medium or high dose of an ICS and a LABA.
Mon, 16 Oct 2023 15:42:38 -0400
Treatment of chronic hepatitis C virus (HCV) infection in pediatric patients ≥ 12 years of age pediatric patients ≥ 12 years of age and weighing ≥ 30 kg without cirrhosis or with compensated cirrhosis.
80.211.154.110